ARDX vs VTRS · rev $215.3M vs rev $7.27B
Ardelyx Inc (ARDX) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Ardelyx Inc (ARDX) is a biotechnology company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ARDX revenue for 2026-06-30 was $215.3M. Net income was -$54.3M. ARDX currently screens at market cap $1.37B.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
ARDX currently screens at market cap $1.37B. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the ARDX and VTRS stock pages for the full models.
Not investment advice.